GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
President Trump praised Dr. Mehmet Oz after the Centers for Medicare and Medicaid Services administrator rushed to help an older woman who collapsed during the speech at Verst Logistics in Kentucky....
Blackstone Valley School's star captain Colin Dorgan scored the game-winning goal to send the team to the Division II championship — just weeks after his trans dad, Robert, gunned down his family at a...
Kick streamers Zavalahimself and Amanda Solis were live-streaming a day out with a child inside a Journeys store at Westfield Santa Anita Mall when police......
